EGFR and neoplasm: Our results demonstrate only a moderate correlation between EGFR gene status in primary tumours and in corresponding metastatic sites (κ=0.49, P=0.0002), and suggest that in patients with mCRC, EGFR evaluation by FISH performed only in primary tumour may not be accurate enough to select candidates for a targeted therapy.